Counterpoint Mutual Funds LLC Has $735,000 Stock Holdings in Clover Health Investments, Corp. (NASDAQ:CLOV)

Counterpoint Mutual Funds LLC raised its holdings in Clover Health Investments, Corp. (NASDAQ:CLOV) by 153.0% in the fourth quarter, Holdings Channel reports. The fund owned 233,392 shares of the company’s stock after acquiring an additional 141,148 shares during the period. Counterpoint Mutual Funds LLC’s holdings in Clover Health Investments were worth $735,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of CLOV. Geode Capital Management LLC increased its holdings in Clover Health Investments by 21.9% during the 3rd quarter. Geode Capital Management LLC now owns 4,828,701 shares of the company’s stock worth $13,622,000 after purchasing an additional 868,501 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Clover Health Investments by 5.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company’s stock valued at $8,461,000 after buying an additional 150,550 shares during the last quarter. State Street Corp grew its position in shares of Clover Health Investments by 65.0% in the 3rd quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after acquiring an additional 862,621 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its holdings in Clover Health Investments by 75.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock worth $3,181,000 after purchasing an additional 485,987 shares during the period. Finally, Swiss National Bank increased its holdings in shares of Clover Health Investments by 6.3% during the 4th quarter. Swiss National Bank now owns 802,100 shares of the company’s stock worth $2,527,000 after acquiring an additional 47,700 shares during the last quarter. 19.77% of the stock is owned by institutional investors.

Clover Health Investments Price Performance

Shares of Clover Health Investments stock opened at $3.66 on Monday. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.87. The firm has a market capitalization of $1.87 billion, a P/E ratio of -18.30 and a beta of 2.00. The company’s 50 day moving average price is $4.12 and its two-hundred day moving average price is $3.63.

Insider Buying and Selling

In related news, Director Carladenise Armbrister Edwards sold 200,000 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $3.61, for a total value of $722,000.00. Following the completion of the transaction, the director now owns 273,227 shares in the company, valued at $986,349.47. This trade represents a 42.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Karen Soares sold 52,500 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $3.80, for a total transaction of $199,500.00. Following the sale, the general counsel now directly owns 1,299,663 shares in the company, valued at $4,938,719.40. The trade was a 3.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 327,500 shares of company stock worth $1,197,500 in the last 90 days. Insiders own 22.28% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CLOV. Craig Hallum initiated coverage on shares of Clover Health Investments in a research note on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price target on the stock. Canaccord Genuity Group boosted their price target on Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a research note on Monday, March 3rd.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.